Therapeutic antibodies against cancer stem cells: a promising approach Smarakan SnehaRohit Pravin NagareTrivadi Sundaram Ganesan Review 24 August 2017 Pages: 1383 - 1398
Autoimmune diabetes induced by PD-1 inhibitor—retrospective analysis and pathogenesis: a case report and literature review Marie-Léa GauciPauline LalyJean-François Gautier Original Article 20 June 2017 Pages: 1399 - 1410
Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells Timothy T. SpearYuan WangMichael I. Nishimura Original Article 20 June 2017 Pages: 1411 - 1424
The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity Fiona C. ThistlethwaiteDavid E. GilhamRobert E. Hawkins Original Article Open access 28 June 2017 Pages: 1425 - 1436
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer Robert WesolowskiMegan C. DugganWilliam E. Carson III Original Article 07 July 2017 Pages: 1437 - 1447
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases Erna-Elise PaulsenThomas K. KilvaerTom Donnem Original Article Open access 13 July 2017 Pages: 1449 - 1461
Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies Margrethe RaspotnigMette HaugenChristian A. Vedeler Original Article 14 July 2017 Pages: 1463 - 1471
Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy Frida Ewald SanderMalin NilssonAnna Martner Original Article Open access 18 July 2017 Pages: 1473 - 1484
IL-4 blockade alters the tumor microenvironment and augments the response to cancer immunotherapy in a mouse model Shuku-ei ItoHidekazu ShirotaChikashi Ishioka Original Article 21 July 2017 Pages: 1485 - 1496
“Tumor immunology meets oncology (TIMO) XII”, April 28th–30th 2016, Halle/Saale, Germany Barbara Seliger Meeting Report 10 July 2017 Pages: 1497 - 1503
CAR T cells targeting solid tumors: carcinoembryonic antigen (CEA) proves to be a safe target Astrid HolzingerHinrich Abken Letter to the Editors 28 July 2017 Pages: 1505 - 1507